Physician profile
Eileen Ford Farwick
NPI 1649268137
$3,511.46
in general payments reported to CMS, 2019-2025
36 companies · $1,228 in 2025
The $1,228 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.80 · 2020: $116 · 2021: $170 · 2022: $503 · 2023: $805 · 2024: $596 · 2025: $1,228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,448 · Education: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,448.24 |
| Education | $179.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $593.11 | 2019-2025 | Veozah, Myrbetriq |
| Axonics, INC. | $292.45 | 2020-2024 | Axonics |
| Abbvie INC. | $261.47 | 2021-2025 | |
| Boston Scientific Corporation | $215.45 | 2023-2024 | Upsylon |
| Escala Medical INC. | $208.40 | 2025 | |
| Pfizer INC. | $161.91 | 2021-2024 | |
| Femselect INC. | $154.52 | 2025 | Enplace |
| Medtronic, INC. | $150.35 | 2021-2025 | Ligasure |
| Neuraxis, INC. | $144.15 | 2025 | |
| Exact Sciences Corporation | $138.41 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Amgen INC. | $126.56 | 2023-2025 | Evenity, Prolia |
| Sumitomo Pharma America, INC. | $124.46 | 2023-2025 | Gemtesa |
| Millicent US INC | $113.25 | 2022-2025 | Intrarosa, Femlyv |
| Caldera Medical, INC | $105.84 | 2023 | Desara |
| Bayer Healthcare Pharmaceuticals INC. | $82.69 | 2025 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $73.24 | 2023 | Tisseel |
| Allergan, INC. | $57.76 | 2020-2022 | |
| Mayne Pharma Commercial LLC | $53.08 | 2025 | |
| Rochester Medical Corporation | $48.33 | 2022 | |
| Mycovia Pharmaceuticals, INC. | $48.03 | 2023 | Vivjoa |
| Agile Therapeutics, INC. | $40.94 | 2022-2023 | Twirla |
| Organon LLC | $33.68 | 2022-2025 | Nexplanon |
| Therapeuticsmd, INC. | $33.17 | 2020-2022 | |
| Hologic Sales and Service, LLC | $30.00 | 2025 | Thinprep 2000 Processor, Aptima |
| Abc Home Medical Supply, INC. | $29.70 | 2023 | |
| Scynexis, INC. | $27.44 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $21.21 | 2023 | Exparel |
| Coloplast Corp | $19.16 | 2025 | |
| Dysis Medical, INC. | $18.81 | 2019 | |
| Gynesonics, INC. | $18.24 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Exeltis, USA INC. | $18.19 | 2021 | |
| Merck Sharp & Dohme LLC | $17.40 | 2024 | Capvaxive, Gardasil 9, Gardasil |
| Dentsply Ih INC. | $15.09 | 2021 | |
| Evofem Biosciences, INC. | $13.50 | 2022 | |
| Medtronic USA, INC. | $12.31 | 2020 | |
| Meditrina | $9.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eileen Farwick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.